Dr Agarwals Eye Hospital Limited (DRAGARWQ) fundamentals
Dr Agarwals Eye Hospital Limited is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as DRAGARWQ (ISIN INE934C01018). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Dr Agarwals Eye Hospital Limited does
Dr. Agarwal's Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.
Valuation and market data
| Last close | ₹5301.00 |
|---|---|
| Market capitalisation | ₹2,491 crore |
| Enterprise value | ₹2,797 crore |
| P/E (TTM) | 0.00 |
| Price to book | 11.89 |
| Price to sales (TTM) | 4.94 |
| Book value per share | ₹445.98 |
| Dividend yield | 19.81% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Mon Apr 20 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹477 crore | ₹94 crore | ₹70 crore | 0.00 |
| Mar 2025 | ₹402 crore | ₹71 crore | ₹55 crore | 116.28 |
| Mar 2024 | ₹324 crore | ₹62 crore | ₹46 crore | 98.64 |
| Mar 2023 | ₹270 crore | ₹49 crore | ₹37 crore | 78.55 |
| Mar 2022 | ₹202 crore | ₹32 crore | ₹24 crore | 51.28 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 72.7% |
|---|---|
| Foreign institutions (FII) | 2.2% |
| Mutual funds | 0.0% |
| Other domestic institutions | 2.0% |
| Retail and others | 23.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.